留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

碎裂QRS波对心脏同步化治疗预后的预测价值

孙煌 罗薇 马米尔 沐回凯 钟蕾 马雪娟 彭云珠 李锐洁

孙煌, 罗薇, 马米尔, 沐回凯, 钟蕾, 马雪娟, 彭云珠, 李锐洁. 碎裂QRS波对心脏同步化治疗预后的预测价值[J]. 昆明医科大学学报, 2020, 41(11): 38-43. doi: 10.12259/j.issn.2095-610X.S20201111
引用本文: 孙煌, 罗薇, 马米尔, 沐回凯, 钟蕾, 马雪娟, 彭云珠, 李锐洁. 碎裂QRS波对心脏同步化治疗预后的预测价值[J]. 昆明医科大学学报, 2020, 41(11): 38-43. doi: 10.12259/j.issn.2095-610X.S20201111
Huang SUN, Wei LUO, Mi-er MA, Hui-kai MU, Lei ZHONG, Xue-juan MA, Yun-zhu PENG, Rui-jie LI. Value of Fragmented QRS in Predicting Prognosis of Patients after Cardiac Resynchronization Therapy[J]. Journal of Kunming Medical University, 2020, 41(11): 38-43. doi: 10.12259/j.issn.2095-610X.S20201111
Citation: Huang SUN, Wei LUO, Mi-er MA, Hui-kai MU, Lei ZHONG, Xue-juan MA, Yun-zhu PENG, Rui-jie LI. Value of Fragmented QRS in Predicting Prognosis of Patients after Cardiac Resynchronization Therapy[J]. Journal of Kunming Medical University, 2020, 41(11): 38-43. doi: 10.12259/j.issn.2095-610X.S20201111

碎裂QRS波对心脏同步化治疗预后的预测价值

doi: 10.12259/j.issn.2095-610X.S20201111
基金项目: 国家自然科学基金资助项目(81260050);云南省科技厅-昆明医科大学应用基础研究联合专项基金资助项目[2017FE467(-133);2018FE001(-038)]
详细信息
    作者简介:

    孙煌(1982~),男,湖南常德人,医学博士,主治医师,主要从事心脏内科心肌疾病、结构性心脏病诊疗工作。罗薇与孙煌对本文有同等贡献

    通讯作者:

    李锐洁,E-mail: li_ruijie@hotmail.com

    彭云珠,E-mail: pengyunzhu0308@163.com

  • 中图分类号: R541.6

Value of Fragmented QRS in Predicting Prognosis of Patients after Cardiac Resynchronization Therapy

  • 摘要:   目的   研究CRT植入前后碎裂QRS(fragmented QRS,fQRS)特征与CRT应答之间的关系。   方法   纳入2016年1月至2018年12月昆明医科大学第一附属医院心脏内科接受CRT植入的心力衰竭患者,分别采集患者CRT植入前和植入后6个月的12导联心电图及超声心动图图像并分析其与CRT应答的关系。   结果   研究纳入108例患者(其中男性78例,占总人数的72.2%),平均年龄(56.5±11.9)岁。共有75例患者(69.4%)对CRT有应答,左室射血分数显著增加[从(30.71±1.92)~(50.61±2.57),P < 0.001],左室舒张末容积显著(LVESV)降低[从(195.26±78.79)~(156.55±84.44), P < 0.001]。CRT植入后,有应答患者心电图中有fQRS导联的数量未改变[CRT植入前后分别为(6.25±2.68) vs (6.03±2.54), P= 0.571],无应答者心电图中fQRS导联数量显著增加[CRT植入前后分别为(6.18±2.20) vs (7.36±2.61),P= 0.013]。多因素Logistic分析显示,QRS时限的降低和CRT植入后fQRS导联数量的减少是CRT应答的独立预测因子。   结论   CRT植入后含fQRS导联的数量增加是CRT无应答的独立预测因子,除QRS宽度及形态以外的心电图特征有助于评估在心力衰竭患者是否适合接受CRT植入。
  • 图  1  12导联心电图fQRS(箭头所指)

    Figure  1.  Fragmented QRS in 12 lead ECG(Arrow)

    表  1  患者基线情况( $\bar x \pm s$

    Table  1.   Baseline characteristics of study population( $\bar x \pm s$

    项目 数值
    年龄(岁) 56.5 ± 11.9
    男性[n(%)] 78(72.2)
    缺血性疾病[n(%)] 21(19.4)
    高血压[n(%)] 31(28.7)
    糖尿病[n(%)] 23(21.3)
    房颤[n(%)] 9(8.3)
    药物[n(%)]
     RAS抑制剂 105(97.2)
     β受体阻滞剂 104(96.3)
     MCRA 95(88.0)
      RAS:肾素-血管紧张素系统;MCRA:盐皮质激素受体拮抗剂。
    下载: 导出CSV

    表  2  根据CRT应答情况分组患者基线特征比较( $\bar x \;\pm\; s$

    Table  2.   Baseline characteristic of CRT patients according to response of CRT( $\bar x \;\pm \;s$

    项目 有应答者(n = 75) 无应答者(n = 33) χ2/t P
    男性[n(%)] 57(76.0) 21(63.6) 1.746 0.186
    年龄(岁) 57.44 ± 11.29 54.45 ± 13.32 1.201 0.232
    缺血性心肌病 9(12.0) 12(36.3) 8.684 0.003*
    LBBB 42(56.0) 18(54.5) 0.020 0.889
    QRS宽度(ms) 157.32 ± 26.71 153.82 ± 22.30 0.658 0.512
    NYHA[n(%)] 0.631 0.427
     II 28(37.5) 15(45.5)
     III-IV 47(62.5) 18(54.5)
    LVEDD(mm) 70.64 ± 9.06 69.27 ± 6.17 0.789 0.432
    LAD(mm) 44.72 ± 8.47 42.82 ± 4.64 1.210 0.229
    LVEF(%) 30.68 ± 8.06 28.82 ± 8.27 1.086 0.282
    LVESV(mL) 199.28 ± 85.53 187.18 ± 50.63 0.755 0.452
    LVEDV(mL) 289.76 ± 95.17 261.45 ± 64.53 1.556 0.123
    fQRS导联数目 5.76 ± 2.99 6.18 ± 2.20 0.728 0.469
      LBBB:左束支传导阻滞;NYHA:纽约心功能分级;LVEDD:左心室舒张末期内径;LVESD:左心室收缩末期内径;LAD:左心房内径;LVEF:左心室射血分数;LVESV:左心室收缩末期容积;LVEDV:左心室舒张末期容积。*P < 0.05。
    下载: 导出CSV

    表  3  CRT前后超声心动图和心电图参数的比较( $\bar x \;\pm \;s$

    Table  3.   Comparison of echocardiographic and electrographic parameters before and after CRT( $\bar x\; \pm \;s$

    指标 有应答 无应答
    之前 之后 P 之前 之后 P
    LVEF(%) 30.71 ± 1.92 50.61 ± 2.57 < 0.001* 28.83 ± 1.27 26.28 ± 1.55 0.005*
    LVESV(mL) 195.26 ± 78.79 156.55 ± 84.44 < 0.001* 187.18 ± 50.63 214.73 ± 64.38 < 0.001*
    QRS宽度(ms) 162.09 ± 22.09 145.87 ± 22.30 < 0.001* 153.82 ± 22.30 164.64 ± 22.22 0.036*
    有fQRS的导联数目 6.25 ± 2.68 6.03 ± 2.54 0.571 6.18 ± 2.20 7.36 ± 2.61 0.013*
      采用配对t检验比较CRT前后表中的参数。LVEF:左心室射血分数;LVESV:左心室收缩末体积。*P < 0.05。
    下载: 导出CSV

    表  4  与CRT应答相关变量的Logistic回归分析

    Table  4.   Logistic regression of factors associated with CRT response.

    项目 OR 95% CI P
    病因学
    扩张性心肌病 16.359 3.324~80.508 0.001
    缺血性心肌病 1
    年龄(每增加10岁) 1.72 1.00~2.96 0.050
    基线LVEF(每增加10%) 5.72 1.95~16.79 0.002
    基线LVEDV(每增加10 mL) 1.15 1.06~1.25 0.001
    术后QRS宽度变化(每增加10 ms) 0.55 0.39~0.76 < 0.001
    术后fQRS导联数量变化(每增加1) 0.798 0.642~0.993 0.043
      CI:可信限;LVEF:左心室射血分数;LVESV:左心室舒张末体积;fQRS:碎裂QRS波。
    下载: 导出CSV
  • [1] Normand C, Linde C, Singh J, Dickstein K. Indications for Cardiac Resynchronization Therapy: A Comparison of the Major International Guidelines. JACC Heart Fail 2018; 6(4): 308-316. doi: 10.1016/j.jchf.2018.01.022
    [2] Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology(ESC). Developed with the special contribution of the Heart Failure Association(HFA)of the ESC. Eur J Heart Fail 2016; 18(8): 891-975. doi: 10.1002/ejhf.592
    [3] Leclercq C, Burri H, Curnis A, et al. Cardiac resynchronization therapy non-responder to responder conversion rate in the more response to cardiac resynchronization therapy with MultiPoint Pacing(MORE-CRT MPP)study: results from Phase I. Eur Heart J 2019; 40(35): 2979-2987. doi: 10.1093/eurheartj/ehz109
    [4] Sohaib SM, Chen Z, Whinnett ZI, et al. Meta-analysis of symptomatic response attributable to the pacing component of cardiac resynchronization therapy. Eur J Heart Fail 2013; 15(12): 1419-1428. doi: 10.1093/eurjhf/hft139
    [5] Daubert C, Behar N, Martins RP, Mabo P, Leclercq C. Avoiding non-responders to cardiac resynchronization therapy: a practical guide. Eur Heart J 2017; 38(19): 1463-1472.
    [6] Das MK, Suradi H, Maskoun W, et al. Fragmented wide QRS on a 12-lead ECG: a sign of myocardial scar and poor prognosis. Circ Arrhythm Electrophysiol 2008; 1(4): 258-68. doi: 10.1161/CIRCEP.107.763284
    [7] Das MK. Can fragmented QRS help in risk-stratifying patients with coronary artery disease and a relatively preserved ejection fraction? Heart Rhythm 2012; 9(6): 936-937. doi: 10.1016/j.hrthm.2012.01.017
    [8] Chanavuth K, Pattara R, Poemlarp M, et al. Baseline fragmented QRS is associated with increased all-cause mortality in heart failure with reduced ejection fraction: A systematic review and meta-analysis[J]. Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc 2019; 24(2): e12597. doi: 10.1111/jce.13139
    [9] Igarashi M, Tada H, Yamasaki H, et al. Fragmented QRS Is a Novel Risk Factor for Ventricular Arrhythmic Events After Receiving Cardiac Resynchronization Therapy in Nonischemic Cardiomyopathy[J]. J Cardiovasc Electrophysiol 2017; 28(3): 327-335. doi: 10.1111/anec.12186
    [10] Chanavuth K, Pattara R, Poemlarp M, et al. Baseline fragmented QRS is associated with increased all-cause mortality in heart failure with reduced ejection fraction: A systematic review and meta-analysis. Annals of noninvasive electrocardiology: the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc 2019; 24(2): e12597. doi: 10.1111/anec.12597
    [11] Das MK, El Masry H. Fragmented QRS and other depolarization abnormalities as a predictor of mortality and sudden cardiac death. Curr Opin Cardiol 2010; 25(1): 59-64. doi: 10.1097/HCO.0b013e328333d35d
    [12] Chung ES, Leon AR, Tavazzi L, et al. Results of the Predictors of Response to CRT (PROSPECT) trial. Circulation 2008; 117(20): 2608-2616. doi: 10.1161/CIRCULATIONAHA.107.743120
    [13] A NS, A RC. Is CRT response rate all about patient selection? International journal of cardiology 2018; 270: 183-184. doi: 10.1016/j.ijcard.2018.06.079
    [14] Rickard J, Michtalik H, Sharma R, et al. Predictors of response to cardiac resynchronization therapy: A systematic review. Int J Cardiol 2016; 225: 345-352. doi: 10.1016/j.ijcard.2016.09.078
    [15] Lawin D, Stellbrink C. Change in indication for cardiac resynchronization therapy? Eur J Cardiothorac Surg 2019; 55(Suppl 1): i11-i6.
    [16] Vernooy K, van Deursen CJ, Strik M, Prinzen FW. Strategies to improve cardiac resynchronization therapy. Nat Rev Cardiol 2014; 11(8): 481-493. doi: 10.1038/nrcardio.2014.67
    [17] Chew DS, Wilton SB, Kavanagh K, et al. Fragmented QRS complexes after acute myocardial infarction are independently associated with unfavorable left ventricular remodeling. J Electrocardiol 2018; 51(4): 607-612. doi: 10.1016/j.jelectrocard.2018.04.004
    [18] Amir A, Amir T, Zahra E. Diffuse fragmented QRS as an index of extensive myocardial scar. Indian pacing and electrophysiology journal 2010; 10(1): 67-68.
    [19] Mohamed H, Lamaan A, Bilal S, Jo M, K DM. Fragmented QRS complexes on 12-lead ECG: a marker of cardiac sarcoidosis as detected by gadolinium cardiac magnetic resonance imaging. Annals of noninvasive electrocardiology: the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc 2009; 14(4): 319-326. doi: 10.1111/j.1542-474X.2009.00320.x
    [20] Luc L, Alexandre C, Olivier C, et al. Relationship between fragmented QRS and no-reflow, infarct size, and peri-infarct zone assessed using cardiac magnetic resonance in patients with myocardial infarction. The Canadian journal of cardiology 2014; 30(2): 204-210. doi: 10.1016/j.cjca.2013.11.026
    [21] Das MK, Maskoun W, Shen C, et al. Fragmented QRS on twelve-lead electrocardiogram predicts arrhythmic events in patients with ischemic and nonischemic cardiomyopathy. Heart Rhythm 2010; 7(1): 74-80. doi: 10.1016/j.hrthm.2009.09.065
    [22] Diaz-Infante E, Mont L, Leal J, et al. Predictors of lack of response to resynchronization therapy. Am J Cardiol 2005; 95(12): 1436-1440. doi: 10.1016/j.amjcard.2005.02.009
    [23] Rickard J, Zardkoohi O, Popovic Z, et al. QRS fragmentation is not associated with poor response to cardiac resynchronization therapy[J]. Ann Noninvasive Electrocardiol 2011; 16(2): 165-171. doi: 10.1111/j.1542-474X.2011.00424.x
    [24] Hu YR, Hua W, Yang SW, et al. Predictors of non-response to cardiac resynchronization therapy implantation in patients with class I indications: the markedly dilated left ventricular end-diastolic dimension and the presence of fragmented QRS. J Geriatr Cardiol 2019; 16(7): 514-521.
  • [1] 齐汝楠, 史磊, 刘舒媛, 李菁, 史荔.  HLA-DM基因多态性与脊髓灰质炎疫苗诱导抗体应答的相关性, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20240102
    [2] 吴长勇, 王睿, 保苏丽, 李锐洁, 孙煌, 叶雨佳, 徐菲, 彭云珠.  运动康复对心肌梗死大鼠心脏纤维化及心功能的影响, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20231004
    [3] 师雨晗, 李菁, 刘舒媛, 赵婷, 杨净思, 史荔, 梁疆莉.  壮族人群ERAP基因多态性与脊灰疫苗序贯免疫诱导的抗体应答的相关性分析, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20230711
    [4] 史涛, 黄佑庆, 何晓峰, 宁亚, 臧诗旷, 陈艳, 王丹, 梁跃伟.  体外冲击波联合玻璃酸钠治疗膝骨性关节炎的临床疗效, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20220311
    [5] 曹宇霆, 王启贤, 杨萍.  体外心脏震波治疗心肌纤维化的研究进展, 昆明医科大学学报.
    [6] 李玉芬, 王晓明.  体外冲击波碎石术(ESWL)与输尿管镜碎石术(URL)治疗输尿管结石的临床比较, 昆明医科大学学报.
    [7] 杨旭, 马润伟, 宋怡, 张晓羽, 王霁阳, 张大勇.  波生坦在围术期治疗先天性心脏病重度肺动脉高压的临床效果, 昆明医科大学学报.
    [8] 蒋美萍.  同步加量调强放射治疗在宫颈癌放疗中的临床观察, 昆明医科大学学报.
    [9] 盖起明.  食道导联心电图鉴别诊断宽QRS心动过速的临床应用, 昆明医科大学学报.
    [10] 白桦.  同步放化疗与序贯化放疗治疗Ⅲ期不能手术非小细胞肺癌的临床疗效, 昆明医科大学学报.
    [11] 薛强.  波生坦联合西地那非治疗先心病合并重度肺动脉高压的临床研究, 昆明医科大学学报.
    [12] 鲁一兵.  波生坦治疗先心病合并重度肺动脉高压的疗效观察, 昆明医科大学学报.
    [13] 胡江天.  机械力作用下细胞骨架及相关信号传导通路应答机制, 昆明医科大学学报.
    [14] 陈利华.  碎裂QRS波与心肌梗死研究现状和进展, 昆明医科大学学报.
    [15] 丁成彦.  超声新技术在慢性心衰心脏同步性检测中的临床应用, 昆明医科大学学报.
    [16] 郭海翔.  2种体外冲击波碎石方法治疗输尿管结石108例对比分析, 昆明医科大学学报.
    [17] 戴海龙.  超声新技术指导下心脏再同步化治疗心功能及相关因子水平观察, 昆明医科大学学报.
    [18] 家兔急性失血性休克及分组治疗的血压、微循环同步观测, 昆明医科大学学报.
    [19] 体外冲击波与高频热疗治疗Ⅲ B型前列腺炎患者168例疗效评价, 昆明医科大学学报.
    [20] 刘杰.  体外冲击波与高频热疗治疗ⅢB型前列腺炎患者168例疗效评价, 昆明医科大学学报.
  • 加载中
图(1) / 表(4)
计量
  • 文章访问数:  2384
  • HTML全文浏览量:  1720
  • PDF下载量:  24
  • 被引次数: 0
出版历程
  • 收稿日期:  2020-08-23
  • 刊出日期:  2020-11-25

目录

    /

    返回文章
    返回